Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb.
Chao DT, Su M, Tanlimco S, Sho M, Choi D, Fox M, Ye S, Hsi ED, Durkin L, Yin J, Zhang Y, Kim H, Starling GC, Culp PA.
Chao DT, et al. Among authors: starling gc.
J Cancer Res Clin Oncol. 2013 Feb;139(2):315-25. doi: 10.1007/s00432-012-1332-x. Epub 2012 Oct 17.
J Cancer Res Clin Oncol. 2013.
PMID: 23073510
Free PMC article.